Drug Profile
Research programme: non-nucleoside reverse transcriptase inhibitors - Numerate
Alternative Names: NNRTIs programme - NumerateLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Numerate
- Class Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in HIV-infections in USA
- 03 Mar 2008 Early research in HIV infections in USA (unspecified route)